Cargando…
Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543101/ https://www.ncbi.nlm.nih.gov/pubmed/37789962 http://dx.doi.org/10.1002/mco2.394 |
| _version_ | 1785114225744543744 |
|---|---|
| author | Xiang, Yuancai Ullah, Irfan Miao, Hongming |
| author_facet | Xiang, Yuancai Ullah, Irfan Miao, Hongming |
| author_sort | Xiang, Yuancai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10543101 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105431012023-10-03 Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1 Xiang, Yuancai Ullah, Irfan Miao, Hongming MedComm (2020) Highlights John Wiley and Sons Inc. 2023-10-01 /pmc/articles/PMC10543101/ /pubmed/37789962 http://dx.doi.org/10.1002/mco2.394 Text en © 2023 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Highlights Xiang, Yuancai Ullah, Irfan Miao, Hongming Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1 |
| title | Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1 |
| title_full | Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1 |
| title_fullStr | Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1 |
| title_full_unstemmed | Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1 |
| title_short | Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1 |
| title_sort | targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1 |
| topic | Highlights |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543101/ https://www.ncbi.nlm.nih.gov/pubmed/37789962 http://dx.doi.org/10.1002/mco2.394 |
| work_keys_str_mv | AT xiangyuancai targetingprogrammeddeathligand2repulsiveguidancemoleculebpathwayanovelstrategytosubduetumorimmunotherapyresistancetoantiprogrammeddeath1programmeddeathligand1 AT ullahirfan targetingprogrammeddeathligand2repulsiveguidancemoleculebpathwayanovelstrategytosubduetumorimmunotherapyresistancetoantiprogrammeddeath1programmeddeathligand1 AT miaohongming targetingprogrammeddeathligand2repulsiveguidancemoleculebpathwayanovelstrategytosubduetumorimmunotherapyresistancetoantiprogrammeddeath1programmeddeathligand1 |